Our Team
STaiMIC is assembling the human infrastructure to match the ambition of its science.
Susan Nasif O-Adorisio, PhD
Founder and CEO
Founder and Chief Executive Officer of STaiMIC. PhD biomedical scientist from KU Leuven, with 20+ years of experience across antiviral R&D, vaccinology, and applied AI in medicine. Advances translational AI and multiomics for underserved communities across Southern Europe, MENA, and beyond. Has led programmes commissioned or funded by the European Commission (DG SANTE), the pharmaceutical industry, and leading Italian academic medical centres, including Università Cattolica del Sacro Cuore and Fondazione Policlinico Gemelli IRCCS, spanning clinical research, digital health, and community outreach. Appointed contributor to the WHO/EU Innovation Platform for Digital and Tech Innovation and the BioExpert Network. Active member of SIIAM and several Italian, British, and European groups focused on AI innovation in healthcare and life sciences. Honoured invited speaker and chair at international STEM conferences.
Dmitry Sergeev, MD, MSc, PhD
Lead, Clinical Data
Leads clinical data for STaiMIC's OncoOmix program. At the German Cancer Research Centre (DKFZ), he has led several research projects — one honoured by Stiftung LebensBlicke — with publications in top-quartile journals (IF >6.2) and three international conferences, while performing a Heidelberg PhD focused on colorectal cancer screening: the exact disease OncoOmix targets. Currently he is involved in the management of the eight-centre Prostate cancer trial, and his applied AI sampling design at Radboud UMC, Netherlands, cut clinical-validation workload by ~90% for breast cancer screening. Add Health Technology Assessment training (UMIT Tirol, Austria) for payer-and regulator fluency, an MD from Sechenov University, Moscow, an MSc in Epidemiology with top grade from Charité Berlin, and operating fluency in English and Russian with working German.
Reem Alaqi, PharmD
Founding Contributor and Site Coordinator
PharmD graduate from Jazan University, graduating with honours and a GPA of 4.5/5. She supports STaiMIC's site coordination and operational activities in Saudi Arabia, contributing to pilot collaborations and research-focused initiatives within the region. Her background combines pharmaceutical training with hands-on laboratory experience in molecular biology, RNA-based workflows, and protein analysis. She has completed advanced training in multi-omics for clinical practice, including genomics, transcriptomics, proteomics, and RNA-seq pipelines, alongside executive-level training in AI applications in healthcare through the Elite Masterclass for Healthcare Leaders. Reem is also certified in Good Clinical Practice (GCP) and has completed advanced research methodology training through the King Fahd Medical Research Center. With native Arabic fluency and professional English proficiency, she bridges scientific, operational, and regional collaboration efforts within STaiMIC's Saudi Arabia programme.